Pegaspargase, gemcitabine, dexamethasone, and cisplatin (P-GDP) combined chemotherapy is effective for newly diagnosed extranodal NK/T-cell lymphoma: a retrospective study

Pegaspargase, gemcitabine, dexamethasone, and cisplatin (P-GDP) combined chemotherapy is effective for newly diagnosed extranodal NK/T-cell lymphoma: a retrospective study

Tao Liu, Fang Zhu, Yin Xiao, Qiuhui Li, Xinxiu Liu, Kunyu Yang, Gang Wu, Liling Zhang Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China Purpose: L-asparaginase or pegaspargase-based chemotherapies have shown promising results...

Full description

Bibliographic Details
Main Authors: Liu T, Zhu F, Xiao Y, Li Q, Liu X, Yang K, Wu G, Zhang L
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:Cancer Management and Research
Subjects:
Extranodal natural killer/T-cell lymphoma
pegaspargase
gemcitabine
efficacy
safety
retrospective study
Online Access:https://www.dovepress.com/pegaspargase-gemcitabine-dexamethasone-and-cisplatin-p-gdp-combined-ch-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/pegaspargase-gemcitabine-dexamethasone-and-cisplatin-p-gdp-combined-ch-peer-reviewed-article-CMAR

Similar Items